Latest Conference Articles

Even when staph bacteria are not drug resistant, clinicians face prescribing drugs that could cause an adverse reaction including kidney injury. A Pittsburgh team looked at the comparative risk of nafcillin vs. oxacillin.

Healthcare providers need to remember the significance of the national issue of effectively combating antibiotic resistance.

Infection prevention is key in wanting to halt the rapid spread of antibiotic resistance.

Right now, what's really important is for hospital staff and healthcare providers to ensure their laboratories can detect antibiotic resistance accurately.

Scott Fridkin, MD, Senior Advisor for Antibiotic Resistance in Healthcare in the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infections Diseases, CDC discussed how state programs can only flourish as healthcare professionals across the board implement existing public health guidelines into their practices.

Adding to research confirming the risk of administering piperacillin/tazobactam in combination with vancomycin, two research teams report that it does not matter whether the drugs are given in an extended infusion or standard infusion.

Vancomycin in combination with Beta-Lactams can cause acute kidney injury, and some combinations are worse than others, researchers warn.

Delayed-release dimethyl fumarate (DMF) proved to be safe and effective in two phase 3 studies, DEFINE and CONFIRM, for patients with relapsing-remitting multiple sclerosis (RRMS). Gavin Giovannoni, MBBCh, PhD, FRCP, FRCPath, of the Queen Mary University of London and colleagues took a more detailed look to verify the data.

Alemtuzumab is an effective strategy to prevent relapses and other disease activity associated with multiple sclerosis (MS), according to Heinz Wiendl, MD, a professor at the University of Münster. The research will be explained in a poster session at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2015) in Barcelona, Spain.

Race and vitamin D levels may play a crucial role in the risk of multiple sclerosis (MS), according to Annette M. Langer-Gould, MD, PhD, of Kaiser Permanente in Pasadena, California. The findings are set to be presented in a poster session at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2015) in Barcelona, Spain.

It may be the European Society of Cardiology's annual congress, but with abstract submissions from North America and Asia the recent event was further proof that the field is becoming more globalized while still holding to its Localized roots.

Obesity is a growing problem around the world and new research has shown that even small amounts of physical exercise can make a big difference in keeping people from gaining too much weight.

As the European Society of Cardiology wraps up another successful congress in London there remains a buzz about the work being done by doctors around the world to help patients with a variety of conditions.

As oral anticoagulants become more popular and a new generation of the drugs is introduced there are still some questions about the potential risks of taking the medication and whether they outweigh the benefits.

The European Society of Cardiology's annual conference in London highlighted some of the top work being done in the field over the past year.

PCSK9 inhibitors have been the focus of the cardiology community and with the approval of two medications in the past few months these drugs could soon make their way to a large number of patients needing help managing their cholesterol levels using more than just statins.

Congestive heart failure is a serious condition facing people around the world. Early trials of a gene therapy have showed promise to not only help these patients with the condition but also make their hearts healthier.

Just because researchers go into a study with a hypothesis they hope to prove, it does not mean the results will be what they were hoping for.

There is an ever growing list of tests doctors can order for their patients, particularly when it comes to cardiac conditions. Choosing the right test is a very important skill for practitioners to use in their daily practice.

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

On a daily basis cardiologists face patients with a wide variety of conditions. A review of recent studies show just how far the treatment of many of these conditions have come.

If a patient requires bypass surgery one of the factors doctors will look at when considering the operation is the person's blood pressure. A recent study looked at whether it could be safe to operate when the patient's pressure is higher or lower than previously accepted.

When a patient checks into the emergency room, whether on their own or in an ambulance, time is of the essence to make the correct diagnosis. As technology improves so does the ability to make diagnoses in medicine that much faster. This way doctors can treat the patients that need the help the most while the others can be safely discharged and sent home.

Several large groups combined data to look at results of a study on heart failure patients to see whether age and gender affected treatment options prescribed by patients.

While digoxin has been a popular medication in the past, particularly for patients with atrial fibrillation, a recent study looked at whether the medication was indeed beneficial for treatment when compared to placebo or no pharmaceutical therapy at all. Digoxin may be a popular treatment for some patients, but often doctors cannot look at just one condition when treating and have to consider multiple factors and issues.

Treating one patient for an illness can answer some questions for doctors. However, in many cases looking at the larger patient population can answer not only why the patients got sick, but what can be done to keep them healthy in the long run.

With clinical trials becoming more expensive and difficult to arrange in the current medical environment researchers are looking at new ways to test ideas without putting added stress and strain on clinicians.

As value based care becomes a buzz word in the medical industry doctors are learning what it means for their practice and how they can utilize it while still applying the same level of attention to their patients as they did in the past.

A lot has changed in cardiology over time and there is even more change ahead. How doctors handle that change can determine how successful they are in their practice.

As technology improves telemedicine is becoming a more viable option to treat a wide variety of conditions. While the idea of telemedicine can be easily implemented into practice there are still concerns that need to be addressed for the field to progress. These issues can include liability and governance over doctors and where their patients are located.